Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority study.

Autor: Kovács G; Second Department of Pediatrics, Semmelweis University, Budapest, Hungary. Electronic address: kovacs.gabor1@med.semmelweis-univ.hu., Wachtel AE; Department of Pediatrics, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Basharova EV; Oncohematology Center, Chelyabinsk Pediatric Regional Clinical Hospital, Chelyabinsk, Russia., Spinelli T; Helsinn Healthcare SA, Lugano, Switzerland., Nicolas P; Helsinn Healthcare SA, Lugano, Switzerland., Kabickova E; Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2016 Mar; Vol. 17 (3), pp. 332-344. Date of Electronic Publication: 2016 Jan 19.